Sintesis dan Evaluasi Antimalaria In Vitro Turunan Kinin Terhadap Plasmodium falciparum

Salahuddin Salahuddin, K RahmanaEmran, Muhammad Hanafi, Andini Sundowo, P. Nl, Nadia Adipratiwi, Titin Ariyani, E. E. Prabandari, D. Waluyo
{"title":"Sintesis dan Evaluasi Antimalaria In Vitro Turunan Kinin Terhadap Plasmodium falciparum","authors":"Salahuddin Salahuddin, K RahmanaEmran, Muhammad Hanafi, Andini Sundowo, P. Nl, Nadia Adipratiwi, Titin Ariyani, E. E. Prabandari, D. Waluyo","doi":"10.22435/jki.v11i2.3923","DOIUrl":null,"url":null,"abstract":"Nowadays kinin is the most effective antimalarial drug and its used as an alternative in malaria treatment. However, toxicity of quinine restrict its use as an antimalarial drug. Lipophilicity and long half-life (t½) of quinine that reach 10-20 hours are responsible for its toxicity. The aim of this research is to obtain more polar quinine derivatives by means of hydrogen peroxide reactions to reduce the toxicity. The reactions using hydrogen peroxyde is performed analogously to the procedures reported in the literature. Extract of pure anhydrous kinin is purified in coloumn chromatography followed by structure elucidation. Synthetic product is tested in vitro against Plasmodium falciparum. The characterization of reaction products is performed with proton (1H) and carbon 13 (13C) nuclear magnetic resonance (NMR) spectroscopy. It showed that the reaction using reagents led to epoxidation of vinyl substituents of chinuclidine ring with 61,08% yields. Antimalarial test against Plasmodium falciparum obtained 1.250-2.500 μg/mL of IC50 value. The IC50 values indicated that the synthesis products were not potential for malaria treatment.","PeriodicalId":31842,"journal":{"name":"Jurnal Kefarmasian Indonesia","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-08-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jurnal Kefarmasian Indonesia","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22435/jki.v11i2.3923","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Nowadays kinin is the most effective antimalarial drug and its used as an alternative in malaria treatment. However, toxicity of quinine restrict its use as an antimalarial drug. Lipophilicity and long half-life (t½) of quinine that reach 10-20 hours are responsible for its toxicity. The aim of this research is to obtain more polar quinine derivatives by means of hydrogen peroxide reactions to reduce the toxicity. The reactions using hydrogen peroxyde is performed analogously to the procedures reported in the literature. Extract of pure anhydrous kinin is purified in coloumn chromatography followed by structure elucidation. Synthetic product is tested in vitro against Plasmodium falciparum. The characterization of reaction products is performed with proton (1H) and carbon 13 (13C) nuclear magnetic resonance (NMR) spectroscopy. It showed that the reaction using reagents led to epoxidation of vinyl substituents of chinuclidine ring with 61,08% yields. Antimalarial test against Plasmodium falciparum obtained 1.250-2.500 μg/mL of IC50 value. The IC50 values indicated that the synthesis products were not potential for malaria treatment.
抗恶性疟原虫Kinin-Turunan的合成及体外评价
激肽是目前最有效的抗疟药物,也是治疗疟疾的一种替代药物。然而,奎宁的毒性限制了其作为抗疟药物的使用。奎宁的亲脂性和达到10-20小时的长半衰期(t½)是其毒性的原因。本研究的目的是通过过氧化氢反应获得更具极性的奎宁衍生物,以降低毒性。使用过氧化氢的反应类似于文献中报道的程序进行。纯无水激肽提取物经柱层析纯化后进行结构鉴定。合成产物在体外对恶性疟原虫进行了测试。反应产物的表征用质子(1H)和碳13(13C)核磁共振(NMR)光谱进行。结果表明,使用试剂的反应导致了chinucridine环的乙烯基取代基的环氧化,产率为61,08%。恶性疟原虫抗疟试验IC50值为1.250-2.500μg/mL。IC50值表明,合成产物不具有治疗疟疾的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
19
审稿时长
16 weeks
文献相关原料
公司名称 产品信息 采购帮参考价格
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信